Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12270582rdf:typepubmed:Citationlld:pubmed
pubmed-article:12270582lifeskim:mentionsumls-concept:C0282402lld:lifeskim
pubmed-article:12270582lifeskim:mentionsumls-concept:C0043210lld:lifeskim
pubmed-article:12270582lifeskim:mentionsumls-concept:C0021368lld:lifeskim
pubmed-article:12270582lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:12270582lifeskim:mentionsumls-concept:C0232970lld:lifeskim
pubmed-article:12270582lifeskim:mentionsumls-concept:C0445550lld:lifeskim
pubmed-article:12270582lifeskim:mentionsumls-concept:C2745888lld:lifeskim
pubmed-article:12270582pubmed:issue1lld:pubmed
pubmed-article:12270582pubmed:dateCreated2002-9-24lld:pubmed
pubmed-article:12270582pubmed:abstractTextConcentrations of soluble fractions of cell adhaesion molecules [sCAM], C-reactive protein (CRP) and serum amyloid A (SAA) are predictive for future cardiovascular events in postmenopausal women. The effect of hormone replacement therapy (HRT) on these inflammatory markers is not uniform. In the presented study the effect of a low-dose HRT preparation, on sCAM, CRP and SAA in healthy postmenopausal women was evaluated.lld:pubmed
pubmed-article:12270582pubmed:languageenglld:pubmed
pubmed-article:12270582pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12270582pubmed:citationSubsetIMlld:pubmed
pubmed-article:12270582pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12270582pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12270582pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12270582pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12270582pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12270582pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12270582pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12270582pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12270582pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12270582pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12270582pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12270582pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12270582pubmed:statusMEDLINElld:pubmed
pubmed-article:12270582pubmed:monthSeplld:pubmed
pubmed-article:12270582pubmed:issn0378-5122lld:pubmed
pubmed-article:12270582pubmed:authorpubmed-author:KyurkchievSta...lld:pubmed
pubmed-article:12270582pubmed:authorpubmed-author:GoudevAssenAlld:pubmed
pubmed-article:12270582pubmed:authorpubmed-author:GeorgievDimit...lld:pubmed
pubmed-article:12270582pubmed:authorpubmed-author:KoychevaNeven...lld:pubmed
pubmed-article:12270582pubmed:authorpubmed-author:ManasievNicko...lld:pubmed
pubmed-article:12270582pubmed:copyrightInfoCopyright 2002 Elsevier Science Ireland Ltd.lld:pubmed
pubmed-article:12270582pubmed:issnTypePrintlld:pubmed
pubmed-article:12270582pubmed:day30lld:pubmed
pubmed-article:12270582pubmed:volume43lld:pubmed
pubmed-article:12270582pubmed:ownerNLMlld:pubmed
pubmed-article:12270582pubmed:authorsCompleteYlld:pubmed
pubmed-article:12270582pubmed:pagination49-53lld:pubmed
pubmed-article:12270582pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12270582pubmed:meshHeadingpubmed-meshheading:12270582...lld:pubmed
pubmed-article:12270582pubmed:meshHeadingpubmed-meshheading:12270582...lld:pubmed
pubmed-article:12270582pubmed:meshHeadingpubmed-meshheading:12270582...lld:pubmed
pubmed-article:12270582pubmed:meshHeadingpubmed-meshheading:12270582...lld:pubmed
pubmed-article:12270582pubmed:meshHeadingpubmed-meshheading:12270582...lld:pubmed
pubmed-article:12270582pubmed:meshHeadingpubmed-meshheading:12270582...lld:pubmed
pubmed-article:12270582pubmed:meshHeadingpubmed-meshheading:12270582...lld:pubmed
pubmed-article:12270582pubmed:meshHeadingpubmed-meshheading:12270582...lld:pubmed
pubmed-article:12270582pubmed:meshHeadingpubmed-meshheading:12270582...lld:pubmed
pubmed-article:12270582pubmed:meshHeadingpubmed-meshheading:12270582...lld:pubmed
pubmed-article:12270582pubmed:meshHeadingpubmed-meshheading:12270582...lld:pubmed
pubmed-article:12270582pubmed:meshHeadingpubmed-meshheading:12270582...lld:pubmed
pubmed-article:12270582pubmed:meshHeadingpubmed-meshheading:12270582...lld:pubmed
pubmed-article:12270582pubmed:meshHeadingpubmed-meshheading:12270582...lld:pubmed
pubmed-article:12270582pubmed:meshHeadingpubmed-meshheading:12270582...lld:pubmed
pubmed-article:12270582pubmed:meshHeadingpubmed-meshheading:12270582...lld:pubmed
pubmed-article:12270582pubmed:meshHeadingpubmed-meshheading:12270582...lld:pubmed
pubmed-article:12270582pubmed:year2002lld:pubmed
pubmed-article:12270582pubmed:articleTitleEffects of low dose hormone replacement therapy on markers of inflammation in postmenopausal women.lld:pubmed
pubmed-article:12270582pubmed:affiliationDepartment of Internal Medicine 2, Preventive Cardiology Clinic, Medical University Sofia, 1 G Sofiiski St, 1431 Sofia, Bulgaria. goudev@hotmail.comlld:pubmed
pubmed-article:12270582pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12270582pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12270582lld:pubmed